Skip to content

Curcumin Supplementation for Gynecological Diseases

Curcumin Supplementation for Gynecological Diseases Including Pelvic Inflammatory Disease Endometritis, Endometriosis: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03016039
Enrollment
180
Registered
2017-01-10
Start date
2017-01-07
Completion date
2021-10-31
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Curcumin Use for Gynecological Conditions

Brief summary

To use curcumin supplementation as an additive treatment to induce clinical, biochemical response and remission in patients with suspected Pelvic inflammatory disease, Tubo ovarian abcess, Endometritis, wound infection. Hypothesis: An addition of oral curcumin to highly suspected PID/Endometritis/Wound infection patients may augment clinical and biochemical response and accelerates the improvements of the sign symptoms and reported outcomes of those diseases.

Detailed description

Pelvic inflammatory disease (PID), Endometritis, Wound infection are infections of the female reproductive system. Although PID is a well known pathophysiology the diagnosis method I not well established and its true magnitude is unknown. Many women report that they have been treated for PID when they did not suffer from it and vice versa. Hence the main way to diagnose remains clinical and currently there is no well-established biochemical marker. In endometritis and wound infection the cause may be known but the pathogens involved in the disease formation vary as for this broad spectrum antibiotic is needed. Aims: To use curcumin supplementation as an additive treatment to induce clinical, biochemical response and remission in patients with suspected PID, Tubo ovarian abcess, Endometritis, wound infection. Hypothesis: An addition of oral curcumin to highly suspected PID/Endometritis/Wound infection patients may augment clinical and biochemical response and accelerates the improvements of the sign symptoms and reported outcomes of those diseases. Rational: Curcumin treatment has been shown to safe and efficient in inflammatory states such as in mild-moderate Ulcerative colitis (UC), obesity, and type II diabetes mellitus when used as an add-on to conventional treatment. In the gynecology and especially in the PID/Tubo ovarian abcess diseases the use of Curcumin as a supplement has never been studied. In the future it is necessary to study the use of curcumin in different gynecological diseases (e.g Endometriosis/Premenstrual syndrome (PMS) and also in gynecology oncology) in which inflammatory and immune response are involve in the disease.

Interventions

DIETARY_SUPPLEMENTCurcumin supplementation

use of curcumin supplementation as an additive treatment to the conventional treatment

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 52 Years
Healthy volunteers
No

Inclusion criteria

* Age above 18 * The patient was admitted with a diagnosis of Pelvic inflammatory disease / Tubo ovarian abcess, surgical wound infection, Endometritis * No Antibiotic treatment was given prior to her recruitment for the study * The women is not in menopause

Exclusion criteria

* Age below 18 and above 52 * Antibiotic treatment was given prior to her recruitment for the study * The women is in menopause * Pregnant women. Known other inflammatory disease.

Design outcomes

Primary

MeasureTime frame
Change in the Levels of C reactive proteinat recruitment and after two week and after one month
Change in the Levels of White blood cellsat recruitment and after two week and after one month

Countries

Israel

Contacts

Primary ContactNissim ARBIB, MD
Nisim.Arbib@clalit.org.il0097297471783

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026